Fmoc-Glu(ODmab)-OH,
268730-86-5,
(S)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-5-((4-((1-(4,4-dimethyl-2,6-dioxocyclohexylidene)-3-methylbutyl)amino)benzyl)oxy)-5-oxopentanoic acid,
DTXSID80718515,
CF-797,
MFCD00797873,
ZINC150339216,
AS-30723,
FT-0696175,
730F865,
J-010834,
J-016578,
(2S)-5-[(4-{[1-(4,4-Dimethyl-2,6-dioxocyclohexylidene)-3-methylbutyl]amino}phenyl)methoxy]-2-({[(9H-fluoren-9-yl)methoxy]carbonyl}amino)-5-oxopentanoic acid (non-preferred name),
Fmoc-L-glutamic acid-alpha-4-[N-{1-(4,4-dimethyl-2,6-dioxocyclohexylidene)-3-methylbutyl}amino] benzyl ester,
Fmoc-L-glutamic acid-gamma-4-[N-{1-(4,4-dimethyl-2,6-dioxocyclohexylidene)-3-methylbutyl}amino] benzyl ester,
L-Glutamic acid,N-[(9H-fluoren-9-ylmethoxy)carbonyl]-,5-[[4-[[1-(4,4-dimethyl-2,6-dioxocyclohexylidene)-3-methylbutyl]amino]phenyl]methyl]ester,
FMOC-GLU -OH,
Fmoc-Glu(Odmab)-OH - 5G 5g,
A7893,
172611-75-5,
L-Glutamic acid, N-[(9H-fluoren-9-ylmethoxy)carbonyl]-, 5-[[4-[[1-(4,4-dimethyl-2,6-dioxocyclohexylidene)-3-methylbutyl]amino]phenyl]methyl] ester,